Showing results (171-180 of 232) with videos related to
Sort By:
Pageof 24
Scandinavian Journal of Gastroenterology. Supplement|June 20, 2006
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up studyFrank L Wolters, Maurice G Russel, Jildou Sijbrandij, et al.Gut|September 18, 2013
Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndromeMira M Wouters, Diether Lambrechts, Michael Knapp, et al.Journal of Crohn'S & Colitis|November 20, 2025
Benefit-Risk Profile of Upadacitinib: Exploratory Post Hoc Analysis of Phase 2b/3 Studies in Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseSeverine Vermeire, Jean-Frederic Colombel, Silvio Danese, et al.Journal of Crohn'S & Colitis|September 30, 2016
Long-term Efficacy of Vedolizumab for Ulcerative ColitisEdward V Loftus, Jean-Frédéric Colombel, Brian G Feagan, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 9, 2025
Change in fatigue in patients with ulcerative colitis or Crohn's disease initiating biologic therapyEdouard Louis, Peter Bossuyt, Arnaud Colard, et al.Journal of Pediatric Gastroenterology and Nutrition|February 3, 2016
Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-upElisabeth De Greef, Ilse Hoffman, Francoise Smets, et al.Endoscopy|January 16, 2019
Impact of endoscopy system, high definition, and virtual chromoendoscopy in daily routine colonoscopy: a randomized trialPhilip Roelandt, Ingrid Demedts, Hilde Willekens, et al.Gastroenterology|September 6, 2006
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluationSelwyn Odes, Hillel Vardi, Michael Friger, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2025
Extended Risankizumab Treatment in Patients With Crohn's Disease Who Did Not Achieve Clinical Response to Induction TreatmentRemo Panaccione, Marc Ferrante, Iris Dotan, et al.Journal of Crohn'S & Colitis|August 31, 2023
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label ExtensionSilvio Danese, Remo Panaccione, Maria T Abreu, et al.Pageof 24